Cited by

• Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.

  Terczyńska-Dyla E, Bibert S, Duong FH, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Malinverni R, Mangia A, Moradpour D, Müllhaupt B, Negro F, Santoro R, Semela D, Semmo N; Swiss Hepatitis C Cohort Study Group; Heim MH, Bochud PY, Hartmann R. Terczyńska-Dyla E, et al. Nat Commun. 2014 Dec 23;5:5699. doi: 10.1038/ncomms6699. Nat Commun. 2014. PMID: 25534433
• Epidemiology and natural history of HCV infection.

  Hajarizadeh B, Grebely J, Dore GJ. Hajarizadeh B, et al. Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):553-62. doi: 10.1038/nrgastro.2013.107. Epub 2013 Jul 2. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23817321 Review.
• Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland.

  Müllhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, Semela D, Negro F. Müllhaupt B, et al. PLoS One. 2015 Jun 24;10(6):e0125214. doi: 10.1371/journal.pone.0125214. eCollection 2015. PLoS One. 2015. PMID: 26107467 Free PMC article.
• IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction.

  Bibert S, Roger T, Calandra T, Bochud M, Cerny A, Semmo N, Duong FH, Gerlach T, Malinverni R, Moradpour D, Negro F, Müllhaupt B, Bochud PY; Swiss Hepatitis C Cohort Study. Bibert S, et al. J Exp Med. 2013 Jun 3;210(6):1109-16. doi: 10.1084/jem.20130012. Epub 2013 May 27. J Exp Med. 2013. PMID: 23712427 Free PMC article.
• Modelling the impact of different testing strategies for HCV infection in Switzerland.

  Sadeghimehr M, Bertisch B, Schaetti C, Wandeler G, Richard JL, Scheidegger C, Keiser O, Estill J. Sadeghimehr M, et al. J Virus Erad. 2019 Nov 4;5(4):191-203. doi: 10.1016/S2055-6640(20)30036-4. J Virus Erad. 2019. PMID: 31754442 Free PMC article.